SG11201610349SA - Dosing regimens for treating and/or preventing cerebral amyloidoses - Google Patents
Dosing regimens for treating and/or preventing cerebral amyloidosesInfo
- Publication number
- SG11201610349SA SG11201610349SA SG11201610349SA SG11201610349SA SG11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA
- Authority
- SG
- Singapore
- Prior art keywords
- treating
- dosing regimens
- preventing cerebral
- cerebral amyloidoses
- amyloidoses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461979408P | 2014-04-14 | 2014-04-14 | |
| US14/684,967 US9675627B2 (en) | 2014-04-14 | 2015-04-13 | Dosing regimens for treating and/or preventing cerebral amyloidoses |
| PCT/US2015/025733 WO2015160796A1 (en) | 2014-04-14 | 2015-04-14 | Dosing regimens for treating and/or preventing cerebral amyloidoses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201610349SA true SG11201610349SA (en) | 2017-01-27 |
Family
ID=53015935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201610349SA SG11201610349SA (en) | 2014-04-14 | 2015-04-14 | Dosing regimens for treating and/or preventing cerebral amyloidoses |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9675627B2 (enExample) |
| EP (1) | EP3131547A1 (enExample) |
| JP (1) | JP6662789B2 (enExample) |
| KR (1) | KR20170003576A (enExample) |
| CN (1) | CN107148270A (enExample) |
| AU (1) | AU2015247859B2 (enExample) |
| CA (1) | CA2945707A1 (enExample) |
| HK (1) | HK1243643A1 (enExample) |
| SG (1) | SG11201610349SA (enExample) |
| WO (1) | WO2015160796A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2490712T3 (pl) * | 2009-10-19 | 2015-12-31 | Amicus Therapeutics Inc | Sposób leczenia choroby Alzheimera przy zastosowaniu chaperonów farmakologicznych dla zwiększenia aktywności gangliozydaz |
| US9994589B2 (en) | 2015-12-14 | 2018-06-12 | Amicus Therapeutics, Inc. | Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy |
| WO2020023390A1 (en) | 2018-07-25 | 2020-01-30 | Modernatx, Inc. | Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4407957A (en) | 1981-03-13 | 1983-10-04 | Damon Corporation | Reversible microencapsulation of a core material |
| SG47470A1 (en) | 1991-04-25 | 1998-04-17 | Univ Brown Res Found | Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products |
| US5766846A (en) | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| NZ257212A (en) | 1992-09-29 | 1996-11-26 | Inhale Therapeutic Syst | Parathyroid hormone formulations comprising a biologically active n-terminal fragment of the hormone |
| FR2718357B1 (fr) | 1994-04-06 | 1997-10-03 | Defarges Alain Moreau | Perfectionnements apportés à un dispositif d'injection par jet sans aiguille. |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US5654007A (en) | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| CA2526173A1 (en) | 2003-05-22 | 2004-12-02 | The Hospital For Sick Children | Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| CN104771402A (zh) | 2005-06-08 | 2015-07-15 | 阿米库斯治疗学公司 | 溶酶体酶编码基因突变相关的cns紊乱的治疗 |
| PL2533050T6 (pl) * | 2006-05-16 | 2016-05-31 | Amicus Therapeutics Inc | Możliwości leczenia choroby Fabry'ego |
| AU2007260812B2 (en) | 2006-06-23 | 2012-08-16 | Amicus Therapeutics, Inc. | Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| US9056101B2 (en) | 2007-04-26 | 2015-06-16 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
| WO2011011181A1 (en) | 2009-07-01 | 2011-01-27 | Amicus Therapeutics, Inc. | Pharmacological chaperones for the treatment of alzheimer's disease |
| PL2490712T3 (pl) | 2009-10-19 | 2015-12-31 | Amicus Therapeutics Inc | Sposób leczenia choroby Alzheimera przy zastosowaniu chaperonów farmakologicznych dla zwiększenia aktywności gangliozydaz |
| SG193379A1 (en) * | 2011-03-11 | 2013-10-30 | Amicus Therapeutics Inc | Dosing regimens for the treatment of fabry disease |
| BR112014014808A2 (pt) * | 2011-12-22 | 2018-09-25 | Centogene Ip Gmbh | combinações de um composto que tem a capacidade de reorganizar uma enzima lisossômica e ambroxol e/ou um derivado de ambroxol, sua utilização, preparação farmacêutica e seu método de preparação |
| PT2844279T (pt) * | 2012-05-03 | 2021-03-11 | Amicus Therapeutics Inc | Esquema posológico para o tratamento da doença de pompe |
-
2015
- 2015-04-13 US US14/684,967 patent/US9675627B2/en active Active
- 2015-04-14 JP JP2016562965A patent/JP6662789B2/ja not_active Expired - Fee Related
- 2015-04-14 AU AU2015247859A patent/AU2015247859B2/en not_active Ceased
- 2015-04-14 SG SG11201610349SA patent/SG11201610349SA/en unknown
- 2015-04-14 KR KR1020167031756A patent/KR20170003576A/ko not_active Withdrawn
- 2015-04-14 EP EP15719362.4A patent/EP3131547A1/en not_active Withdrawn
- 2015-04-14 CA CA2945707A patent/CA2945707A1/en not_active Abandoned
- 2015-04-14 HK HK18103256.3A patent/HK1243643A1/zh unknown
- 2015-04-14 CN CN201580031471.1A patent/CN107148270A/zh active Pending
- 2015-04-14 WO PCT/US2015/025733 patent/WO2015160796A1/en not_active Ceased
-
2017
- 2017-06-12 US US15/619,785 patent/US20170273996A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015247859A1 (en) | 2016-12-01 |
| US9675627B2 (en) | 2017-06-13 |
| EP3131547A1 (en) | 2017-02-22 |
| JP6662789B2 (ja) | 2020-03-11 |
| US20170273996A1 (en) | 2017-09-28 |
| CN107148270A (zh) | 2017-09-08 |
| US20160008383A1 (en) | 2016-01-14 |
| JP2017511372A (ja) | 2017-04-20 |
| CA2945707A1 (en) | 2015-10-22 |
| HK1243643A1 (zh) | 2018-07-20 |
| WO2015160796A1 (en) | 2015-10-22 |
| KR20170003576A (ko) | 2017-01-09 |
| AU2015247859B2 (en) | 2020-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252631A0 (en) | Activin-actrii antagonists and uses for the treatment of anemia | |
| SG11201609734VA (en) | Devices and methods for treating lower extremity vasculature | |
| IL250685A0 (en) | Medicinal substance induces cytotoxicity | |
| AU362358S (en) | Pet treat | |
| SI3215147T1 (sl) | Nevroatenuacijske spojine norketamina in postopki | |
| GB201502084D0 (en) | Catheter devices and related methods | |
| IL250045A0 (en) | Methods for the treatment or prevention of ophthalmological conditions | |
| LT3189074T (lt) | Kompozicijos ir būdai skirti uždegimo gydymui ir prevencijai | |
| IL251660A0 (en) | A method for measured dosage and a mechanism for its application | |
| IL251107A0 (en) | Compounds and methods | |
| IL251616A0 (en) | Methods and compounds for the treatment and prevention of muscle loss | |
| PL3186013T3 (pl) | Urządzenie do obróbki przedmiotów | |
| IL252904A0 (en) | Methods and factors for treating diseases | |
| ZA201703771B (en) | Compositions and methods for treating hyperkalemia | |
| IL250114A0 (en) | Methods and compositions for the treatment of hiv-related diseases | |
| GB201604707D0 (en) | Elevator exclusive usage method and device | |
| SG11201610349SA (en) | Dosing regimens for treating and/or preventing cerebral amyloidoses | |
| IL255012A0 (en) | Preparations and methods for treating skin conditions | |
| IL246637A0 (en) | Preparations and methods for the treatment of intracerebral hemorrhage | |
| GB201400311D0 (en) | Treating Susceptibility | |
| IL248506A0 (en) | Dosage regimens of nitisinone for the treatment of alkeptonuria | |
| SG11201804140PA (en) | Acidic-gas treating agent and acidic-gas treating method | |
| HUP1600390A2 (hu) | Kumulatív hatású páncéltörõ eszközök hatásának fokozása megfelelõ robbanóanyag és bélésanyag alkalmazásával és ilyen anyagok | |
| ZA201509077B (en) | Safety net | |
| GB201407949D0 (en) | Compositions and methods for treating biofilms |